Trials / Enrolling By Invitation
Enrolling By InvitationNCT04693663
Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Eye Hospital Pristina Kosovo · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess visual and refractive outcomes after laser vision correction (LVC) - ReLex Smile to correct residual myopic refraction after 6 months of pseudophakic (IOL) implantation. Before SMILE YAG-Laser capsulotomy should be performed on all patients, regardless of posterior capsule ossification, in pseudophakic patients with residual refraction. When the YAG Laser is applied after the SMILE, there will be a diopter change.
Detailed description
The residual myopic refraction after 6 month on pseudophakic patients using Relex-Smile surgery using VisuMax Femtosecond Laser.The residual myopic refractive power is between -0.75D till -5.50D.The optical zone(lenticule diameter) and cap diameter were 6.5 and 7.5 mm respectively.After dissection of both anterior and posterior planes, the lenticule was extracted through 120 degree superior 3.5mm incision and marked with a sterile marker(Viscot-Medster)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Relex-Smile surgery | surgery using Relex-Smile |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2018-06-01
- Completion
- 2026-06-01
- First posted
- 2021-01-05
- Last updated
- 2024-08-27
Locations
1 site across 1 country: Kosovo
Source: ClinicalTrials.gov record NCT04693663. Inclusion in this directory is not an endorsement.